Sign in

NCT05372653CompletedPhase 3

A Long-term Trial of OPA-15406 in Infants With Atopic Dermatitis

A Phase 3, Multicenter, Open-label, Uncontrolled Trial to Evaluate the Efficacy and Safety of OPA-15406 Ointment in Infants Younger Than 2 Years of Age With Atopic Dermatitis

Source: ClinicalTrials.gov · Last updated 30 Mar 2025

Brief summary (registry, in English)

To investigate the efficacy of 0.3% OPA-15406 ointment when administered twice daily for 4 weeks in infants younger than 2 years of age with Atopic Dermatitis

Status (registry)
Completed
Phase (registry)
Phase 3
Study type
Interventional
Enrollment
41 (actual)
First submitted
9 May 2022
Start date
23 May 2022
Primary completion date
29 Dec 2022
Lead sponsor
Otsuka Pharmaceutical Co., Ltd.
NCT number
NCT05372653

What you commit to

  • Study type: Interventional · Phase 3
  • Participants enrolled: 41
  • From 23 May 2022 to the primary completion date, 29 Dec 2022
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • -Subjects who have an AD or contact dermatitis flare-up defined as a rapid intensification of AD, within 28 days prior to the baseline examination

Who the study is looking for

  • Subjects who are diagnosed with AD in accordance with the criteria of the Japanese Dermatological Association
  • Subjects whose AD affects 5% to 40% of BSA (excluding scalp) at the screening and baseline examinations
  • Subjects who have an IGA score of 2 or 3 at the screening and baseline examinations

Age in the registry: 3 months to 2 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Save your city in your profile to sort them by distance.

SiteCityCountrySite status
Sotobo Children's Clinic
Coordinator of this site? Confirm its status
IsumiJapanUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.